BeyondSpring Inc. (BYSI)
NASDAQ·Healthcare·Biotechnology
$1.49
-4.40%
Mkt Cap $60.86M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | — | — | — | -$0.54 | -$0.05 | +90.26% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | — | -$0.05 | — | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | — | -$0.04 | — | — | — |
| Q2 2025 May 12, 2025 | — | — | — | — | -$0.06 | — | — | — |
| Q1 2025 Mar 27, 2025 | — | -$1.44M | — | — | $0.08 | — | — | — |
| Q3 2024 Aug 9, 2024 | — | $500.00K | — | — | -$0.09 | — | — | — |
| Q2 2024 Apr 29, 2024 | $30.00M | $438.00K | -98.54% | — | -$0.11 | — | — | — |
| Q2 2024 Apr 11, 2024 | $30.00M | $500.00K | -98.33% | — | -$0.09 | — | — | — |
| Q1 2024 Feb 28, 2024 | $30.00M | $437.50K | -98.54% | — | -$0.16 | — | — | — |
| Q3 2023 Sep 29, 2023 | — | $438.00K | — | — | -$0.11 | — | — | — |
| Q2 2023 Apr 18, 2023 | $30.00M | $337.50K | -98.88% | -$0.58 | -$0.19 | +67.41% | — | — |
| Q1 2023 Mar 31, 2023 | — | $437.50K | — | — | -$0.16 | — | — | — |
| Q1 2023 Feb 28, 2023 | $340.00K | $338.00K | -0.59% | — | -$0.24 | — | — | — |
| Q3 2022 Sep 30, 2022 | $340.00K | $337.50K | -0.74% | -$0.23 | -$0.19 | +17.81% | — | — |
| Q2 2022 Apr 14, 2022 | $268.50K | $338.00K | +25.88% | -$0.26 | -$0.24 | +7.69% | — | — |
| Q1 2022 Mar 31, 2022 | — | $338.00K | — | — | -$0.24 | — | — | — |
| Q4 2021 Dec 30, 2021 | $170.00K | $337.00K | +98.24% | -$0.58 | -$0.47 | +18.97% | — | — |
| Q3 2021 Sep 10, 2021 | $8.77M | $338.00K | -96.14% | -$0.49 | -$0.49 | +0.00% | — | — |
| Q2 2021 Jun 16, 2021 | — | $338.00K | — | -$0.54 | -$0.44 | +18.52% | — | — |
| Q2 2021 Apr 30, 2021 | — | $180.00K | — | -$0.45 | -$0.52 | -15.56% | — | — |